MissionIR Articles
-
Cytori Therapeutics Inc. (CYTX) Starts Presentation at the Biotech Showcase 2013 Conference
Cytori Therapeutics is a medical technologies company focused on the potential of adult stem cell and regenerative cells from adipose tissue. The company’s Celution® System family of medical devices and instruments is being sold into…
-
Sucampo Pharmaceuticals (SCMP) Starts Presentation at the Biotech Showcase 2013 Conference
Sucampo Pharmaceuticals is a global pharmaceutical company engaged in the development and commercialization of medicines based on prostones, a class of compounds occurring naturally in the body. The company is focused on developing prostone-based compounds…
-
DARA BioSciences, Inc. (DARA) Starts Presentation at the OneMedForum 2013 Conference
DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA…
-
Immunovaccine, Inc. (IMV) Starts Presentation at the OneMedForum 2013 Conference
Immunovaccine is a clinical-stage vaccine development company focused on the advancement of its patented DepoVax vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health. Demonstrating safety and immunogenicity potential, Immunovaccine…
-
Bio-Path Holdings Inc. (BPTH) Starts Presentation at the Biotech Showcase 2013 Conference
Bio-Path Holdings is a biotech company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology, which was designed to systemically distribute nucleic acid drugs throughout the human body via intravenous infusion. BPTH is…
-
CytoSorbents Corporation (CTSO) Starts Presentation at the OneMedForum 2013 Conference
CytoSorbents is a therapeutic device company focused on critical care. The company uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CytoSorbents’ purification technology is based on biocompatible, highly…
-
ReNeuron Group (RNUGF) Starts Presentation at the Biotech Showcase 2013 Conference
ReNeuron Group is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications worldwide. Its lead therapeutic candidate is ReN001 stem cell therapy, which is in clinical development…
-
Inovio Pharmaceuticals Inc. (INO) Starts Presentation at the Biotech Showcase 2013 Conference
Inovio Pharmaceuticals is engaged in the development of synthetic vaccines, with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of universal vaccines capable of providing cross-protection against pathogens, such…
-
FluoroPharma Medical, Inc. (FPMI) Starts Presentation at the OneMedForum 2013 Conference
FluoroPharma Medical is a biopharmaceutical company focused on discovering and developing proprietary PET imaging and products for the evaluation of cardiac disease at the cellular and molecular levels. With licensed technology from the Massachusetts General…
-
Advanced Cell Technology Inc. (ACTC) Starts Presentation at the Biotech Showcase 2013 Conference
Advanced Cell Technology is a biotech company that applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine. ACTC is also developing therapeutic platforms using corneal…
-
Avita Medical Ltd. (AVMXF) Starts Presentation at the Biotech Showcase 2013 Conference
Avita Medical develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The company’s lead product, ReCell® Spray-On Skin™, is CE-marked for Europe, TGA-registered in…
-
MiMedx Group, Inc. (MDXG) Starts Presentation at the OneMedForum 2013 Conference
MiMedx Group is an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants that are processed from human amniotic membrane. The company’s mission is to provide physicians with products and tissues to…
-
Agenus, Inc. (AGEN) Starts Presentation at the OneMedForum 2013 Conference
Agenus is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including…
-
Amorfix Life Sciences Ltd. (ARFXF) Starts Presentation at the Biotech Showcase 2013 Conference
Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s Disease. The company offers two types of products: therapeutics, designed to target and…
-
RXi Pharmaceuticals Corp. (RXII) Starts Presentation at the Biotech Showcase 2013 Conference
RXi Pharmaceuticals is a biotech company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in…
-
Immunomedics, Inc. (IMMU) Receives Notice for Patent Application on Hexavalent Complexes
Immunomedics is a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune diseases, and other serious diseases. The company also has a majority ownership in IBC…
-
ADVENTRX Pharmaceuticals, Inc. (ANX) Starts Presentation at the OneMedForum 2013 Conference
ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for treating various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications…
-
NanoViricides, Inc. (NNVC) Starts Presentation at the OneMedForum 2013 Conference
NanoViricides is a development-stage company engaged in creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide class of drug candidates is designed for the specific purpose of attacking and dismantling enveloped virus particles.…
-
ERBA Diagnostics Inc. (ERB) Starts Presentation at the Biotech Showcase 2013 Conference
ERBA Diagnostics is an emerging company in the global healthcare industry, operating in the core business segment of In Vitro Diagnostics (IVD). ERB’s product range includes a wide range of Clinical Chemistry Analyzers (Photometers &…
-
Viropro (VPRO) Starts Presentation at the Biotech Showcase 2013 Conference
Viropro, through its subsidiaries, engages in the contract research, development, and manufacturing of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial…
Search Articles
Latest Articles
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
- MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing
- The Untapped Potential of Greenland’s Jameson Land Basin Creates Major Opportunity for Greenland Energy Company (NASDAQ: GLND)
- Regentis Biomaterials Ltd. (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair
- MissionIRNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration